GB8513641D0 - Pharmaceutical composition - Google Patents

Pharmaceutical composition

Info

Publication number
GB8513641D0
GB8513641D0 GB858513641A GB8513641A GB8513641D0 GB 8513641 D0 GB8513641 D0 GB 8513641D0 GB 858513641 A GB858513641 A GB 858513641A GB 8513641 A GB8513641 A GB 8513641A GB 8513641 D0 GB8513641 D0 GB 8513641D0
Authority
GB
United Kingdom
Prior art keywords
pharmaceutical composition
pharmaceutical
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
GB858513641A
Other versions
GB2159715A (en
GB2159715B (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sterwin AG
Original Assignee
Sterwin AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB848414220A external-priority patent/GB8414220D0/en
Application filed by Sterwin AG filed Critical Sterwin AG
Priority to GB08513641A priority Critical patent/GB2159715B/en
Publication of GB8513641D0 publication Critical patent/GB8513641D0/en
Publication of GB2159715A publication Critical patent/GB2159715A/en
Application granted granted Critical
Publication of GB2159715B publication Critical patent/GB2159715B/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
GB08513641A 1984-06-04 1985-05-30 Pharmaceutical composition in sustained release unit dose form and process for its preparation Expired GB2159715B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB08513641A GB2159715B (en) 1984-06-04 1985-05-30 Pharmaceutical composition in sustained release unit dose form and process for its preparation

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB848414220A GB8414220D0 (en) 1984-06-04 1984-06-04 Medicaments in unit dose form
GB08513641A GB2159715B (en) 1984-06-04 1985-05-30 Pharmaceutical composition in sustained release unit dose form and process for its preparation

Publications (3)

Publication Number Publication Date
GB8513641D0 true GB8513641D0 (en) 1985-07-03
GB2159715A GB2159715A (en) 1985-12-11
GB2159715B GB2159715B (en) 1988-05-05

Family

ID=26287812

Family Applications (1)

Application Number Title Priority Date Filing Date
GB08513641A Expired GB2159715B (en) 1984-06-04 1985-05-30 Pharmaceutical composition in sustained release unit dose form and process for its preparation

Country Status (1)

Country Link
GB (1) GB2159715B (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE450087B (en) * 1985-10-11 1987-06-09 Haessle Ab GRAINS WITH CONTROLLED RELEASE OF PHARMACIFICALLY ACTIVE SUBSTANCES APPLIED SIGNED ON A COMPACT INSULABLE NUCLEAR MATERIAL
SE455836B (en) * 1985-10-11 1988-08-15 Haessle Ab PREPARATION WITH CONTROLLED RELEASE CONTAINING A SALT OF METOPROLOL AND METHOD FOR PREPARING THIS PREPARATION
GB8707416D0 (en) * 1987-03-27 1987-04-29 Wellcome Found Pharmaceutical formulations
SE8703881D0 (en) * 1987-10-08 1987-10-08 Haessle Ab NEW PHARMACEUTICAL PREPARATION
US4971805A (en) * 1987-12-23 1990-11-20 Teysan Pharmaceuticals Co., Ltd. Slow-releasing granules and long acting mixed granules comprising the same
US4938968A (en) * 1988-07-26 1990-07-03 Norjec Development Associates, Inc. Controlled release indomethacin
US5122384A (en) * 1989-05-05 1992-06-16 Kv Pharmaceutical Company Oral once-per-day organic nitrate formulation which does not induce tolerance
US5133974A (en) * 1989-05-05 1992-07-28 Kv Pharmaceutical Company Extended release pharmaceutical formulations
CA2936746C (en) 2014-10-31 2017-06-27 Purdue Pharma Methods and compositions particularly for treatment of attention deficit disorder
US10722473B2 (en) 2018-11-19 2020-07-28 Purdue Pharma L.P. Methods and compositions particularly for treatment of attention deficit disorder

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2313915A1 (en) * 1976-01-26 1977-01-07 Corneille Gilbert Sustained release vincamine microcapsules - with inert core, vincamine (deriv.) intermediate layer and microporous outer coating

Also Published As

Publication number Publication date
GB2159715A (en) 1985-12-11
GB2159715B (en) 1988-05-05

Similar Documents

Publication Publication Date Title
GB2153678B (en) Pharmaceutical composition
EP0173990A3 (en) External pharmaceutical composition
ZA853823B (en) Pharmaceutical composition
GB8426672D0 (en) Pharmaceutical compositions
GB2165451B (en) Pharmaceutical compositions
GB8410290D0 (en) Pharmaceutical compositions
GB8410289D0 (en) Pharmaceutical compositions
GB2153677B (en) Pharmaceutical composition
GB8503513D0 (en) Pharmaceutical compositions
GB8513641D0 (en) Pharmaceutical composition
GB8409961D0 (en) Pharmaceutical compositions
GB2153676B (en) Pharmaceutical composition
GB8518565D0 (en) Pharmaceutical composition
GB8513640D0 (en) Pharmaceutical composition
GB8424512D0 (en) Pharmaceutical composition
GB8429710D0 (en) Pharmaceutical composition
IE841175L (en) Pharmaceutical composition
GB8426767D0 (en) Pharmaceutical composition
GB8424514D0 (en) Pharmaceutical composition
GB8412995D0 (en) Pharmaceutical composition
GB8421583D0 (en) Pharmaceutical composition
GB8421779D0 (en) Pharmaceutical composition
GB8424513D0 (en) Pharmaceutical composition
GB8424167D0 (en) Pharmaceutical composition
GB8424510D0 (en) Pharmaceutical composition

Legal Events

Date Code Title Description
PCNP Patent ceased through non-payment of renewal fee

Effective date: 19930530